Ceritinib
ATC L01ED02 · 8 markets · 12 records
AU 3 records · 2 strengths
- 150 mgcapsuleZYKADIAZYKADIA ceritinib 150 mg hard capsule blister pack
Records without a stated strength · 1 ZYKADIA
US 2 records · 1 strengths
- 150 mgtabletZYKADIA__no_trade__
GB 2 records · 2 strengths
CA 1 records · 1 strengths
- 150 mgcapsuleZYKADIA
SG 1 records · 1 strengths
- 150 mgcapsuleZYKADIA
ES 1 records · 1 strengths
- 150 mgcapsuleZYKADIA
TW 1 records · 1 strengths
- 150 mgcapsuleZYKADIA立克癌 膠囊 150 毫克
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 ZYKADIA
| Strength / form / release | US | GB | CA | AU | SG | ES | TW | EU |
|---|---|---|---|---|---|---|---|---|
| 150 mg capsule | ZYKADIA | ZYKADIA | ZYKADIA ZYKADIA ceritinib 150 mg hard capsule blister pack | ZYKADIA | ZYKADIA | ZYKADIA 立克癌 膠囊 150 毫克 | ||
| 150 mg tablet | No trade name ZYKADIA | ZYKADIA | ||||||
unknown | ZYKADIA | ZYKADIA |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.